pharm - immunomodulators Flashcards

1
Q

cyclosporine MOA

A

binds to cycophilins

blocks differentiation and activation of T cells by binding to calcineurin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cyclosporin use

A

post transplantation anti rejection, some autoimmune dxs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

cyclosporin tox

A

nephrotox, hypertension, hyperglycemia, tremor, gingival hyperplasia, tremor, hirsutism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

tacrolimus tox

A

nephrotox, hypertension, hyperglycemia, tremor, tremor,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

tacrolimus MOA

A

bids to FK-binding protiein, blocks differentiation and activation of T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

tacrolimus use

A

potent antirejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sirolimus/rapamycin MOA

A

inhibits mTOR, inhibits T cell proliferation in reponse to IL-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

sirolimus/rapamycin use

A

post transplant in kidney graft. Also in drug eluding stents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

sirolimus/rapamycin tox

A

hyperlipidemia, thrombocytopenia, leukopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

azathrioprine MOA

A

precursor to 6-mercaptopurine that interferes with metabolism and synthesis of nucleic acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

azathrioprine use

A

kidney transplant, autoimmune disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

azathrioprine tox

A

bone marrow supression (increased by allopurinol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

muromonab-CD3 (OKT3) MOA

A

monoclonal antibidy that binds to and blocks CD3 on T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

muromonab-CD3 (OKT3) use

A

immunosupression after kidney graft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

muromonab-CD3 (OKT3) tox

A

cytokine release storm, hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

use of aldesleukin (IL-2)

A

renal cell carcinoma, metastatic melanoma

17
Q

use of erythopestin

A

anemias (esp in renal failure)

18
Q

use of filgrastim

A

recovery of bone marrow

19
Q

use of sardramostim (Granulocyte-macrophage colony stimulating factor)

A

recovery of bone marrow

20
Q

use of a-interferon

A

hep B/C, KS, leukemia, melanoma

21
Q

use of B interferon

A

MS

22
Q

use of G-interferon

A

chronic granulomatous disease

23
Q

Oprelvekin (IL-11) use

A

thrombocytopenia

24
Q

use of thrombopeoiten

A

thrombocytopenia

25
Q

digoxin immune Fab use

A

digoxin OD

26
Q

infliximab use

A

(target’s TNF-a) crohn’s, RA, psoratic arthritis, ankylosing spondy

27
Q

adalimumab use

A

(target’s TNF-a) crohn’s, RA, psoratic arthritis, ankylosing spondy

28
Q

abiciximab use

A

targets gycoprotein IIb/IIIa - preents cardiac ischemia in unstable angina and in pts treated with PCI

29
Q

trastuzumab (herceptin) use

A

HER2 overexpressing breast cancer

30
Q

rituximab use

A

targets CD20 - B cell non-hodgkin’s lymphoma

31
Q

omalizumab use

A

targets IgE - severe asthma